Leading science, pioneering therapies

CRM Publications

Found 9 results
Filters: Keyword is Transplantation, Heterologous  [Clear All Filters]
2013
Chevaleyre J, Duchez P, Rodriguez L, Vlaski M, Villacreces A, Conrad-Lapostolle V, Praloran V, Ivanovic Z, de la Grange PBrunet.  2013.  Busulfan administration flexibility increases the applicability of scid repopulating cell assay in NSG mouse model.PLoS One. 8(9):e74361.
Ding Y, Hubert CG, Herman J, Corrin P, Toledo CM, Skutt-Kakaria K, Vazquez J, Basom R, Zhang B, Risler JK et al..  2013.  Cancer-Specific requirement for BUB1B/BUBR1 in human brain tumor isolates and genetically transformed cells.Cancer Discov. 3(2):198-211.
Hubert CG, Bradley RK, Ding Y, Toledo CM, Herman J, Skutt-Kakaria K, Girard EJ, Davison J, Berndt J, Corrin P et al..  2013.  Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A.Genes Dev. 27(9):1032-45.
Zheng B, Li G, Chen WCW, Deasy BM, Pollett JB, Sun B, Drowley L, Gharaibeh B, Usas A, Péault B et al..  2013.  Human myogenic endothelial cells exhibit chondrogenic and osteogenic potentials at the clonal level.J Orthop Res. 31(7):1089-95.
Chen C-W, Okada M, Proto JD, Gao X, Sekiya N, Beckman SA, Corselli M, Crisan M, Saparov A, Tobita K et al..  2013.  Human pericytes for ischemic heart repair.Stem Cells. 31(2):305-16.
Stricker SH, Feber A, Engström PG, Carén H, Kurian KM, Takashima Y, Watts C, Way M, Dirks P, Bertone P et al..  2013.  Widespread resetting of DNA methylation in glioblastoma-initiating cells suppresses malignant cellular behavior in a lineage-dependent manner.Genes Dev. 27(6):654-69.
2009
Pollard SM, Yoshikawa K, Clarke ID, Danovi D, Stricker S, Russell R, Bayani J, Head R, Lee M, Bernstein M et al..  2009.  Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens.Cell Stem Cell. 4(6):568-80.
2008
Hay DC, Fletcher J, Payne C, Terrace JD, Gallagher RCJ, Snoeys J, Black JR, Wojtacha D, Samuel K, Hannoun Z et al..  2008.  Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling.Proc Natl Acad Sci U S A. 105(34):12301-6.
1996
Mullins LJ, Mullins JJ.  1996.  Transgenesis in the rat and larger mammals.J Clin Invest. 97(7):1557-60.